Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
09/24/2002 | US6455050 Human administration comprising a protective, highly-immunogenic, non-immunopotentiating copurified mixture of hn and f glycoproteins of human parainfluenza type 3 prepared by copurification from native piv-3 virus by affinity |
09/24/2002 | US6454950 Micell-forming thermoseparating polymer, mixed with water to the concentration of its lowest critical solution temperature and raising the temperature from below to above this temperature to give two phases |
09/24/2002 | CA2105282C Preparation of factor ix |
09/24/2002 | CA2065325C Cdr grafted anti-cea antibodies and their production |
09/24/2002 | CA2063273C Surfactant compositions and methods |
09/19/2002 | WO2002073373A2 Ensemble-based strategy for the design of protein pharmaceuticals |
09/19/2002 | WO2002073201A1 Reagents for labeling protein |
09/19/2002 | WO2002072830A2 Proteins associated with cell growth, differentiation, and death |
09/19/2002 | WO2002072778A2 Method for identifying inhibitors of g protein coupled receptor signaling |
09/19/2002 | WO2002072636A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
09/19/2002 | WO2002072621A2 Cyclohexapeptide having antimicrobial activity |
09/19/2002 | WO2002072615A1 Method of purifying protein |
09/19/2002 | WO2002072614A2 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins |
09/19/2002 | WO2002050099A3 Process for folding chemically synthesized polypeptides |
09/19/2002 | WO2002010192A3 Somatostatin analogues |
09/19/2002 | WO2002002610A3 Secretion and trafficking molecules |
09/19/2002 | WO2001083521A3 Reductive alkylation process on glycopeptides |
09/19/2002 | WO1997046589A3 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
09/19/2002 | US20020132991 Purifying anionic target proteins from a sample; obtain mixed protein samples, incubate with reversibility binding substrate, purify anionic target proteins |
09/19/2002 | US20020132985 Removing multivalent ions from protein; obtain solution containing protein, adjust hydrogen ion concentration, diafilter solution, recover retentate |
09/19/2002 | US20020132980 Generating phosphorylatable polypeptide; obtain polypeptide, detect mutation, incubate with kinase, monitor phosphorylation of polypeptides |
09/19/2002 | US20020132975 Solid phase native chemical ligation of unprotected or N-terminal cysteine protected peptides in aqueous solution |
09/19/2002 | US20020132763 Deuterated cyclosporine analogs and their use as immunomodulating agents |
09/19/2002 | US20020132762 Contacting the antibiotic with a divalent metal ion and an organic solvent, to extract the lipopeptide antibiotic into the solvent; and contacting the extract of the lipopeptide antibiotic with acid. |
09/19/2002 | US20020130082 Endotoxin adsorbent, and a method of removing endotoxin by using the same |
09/19/2002 | CA2473979A1 Method for identifying inhibitors of g protein coupled receptor signaling |
09/19/2002 | CA2441495A1 Proteins associated with cell growth, differentiation, and death |
09/19/2002 | CA2440467A1 Ensemble-based strategy for the design of protein pharmaceuticals |
09/19/2002 | CA2433353A1 Crystals of whole antibodies and fragments thereof and methods for making and using them |
09/18/2002 | EP1241258A2 Stem cell factor |
09/18/2002 | EP1241178A1 Process for producing functional silk fibroin and utilization of the same |
09/18/2002 | EP1240337A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
09/18/2002 | EP1240200A1 Separation of fibrinogen from plasma proteases |
09/18/2002 | EP1240193A2 Peptide fragments of colostrinin |
09/18/2002 | EP1240181A2 Daptomycin analogs as antibacterial agents |
09/18/2002 | EP1240169A1 Peptide beta-turn mimetic compounds and processes for making them |
09/18/2002 | EP0923308B1 Purification of biologically active peptides from milk |
09/18/2002 | EP0904285B1 Cyclic adhesion inhibitors |
09/18/2002 | EP0759765B1 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
09/18/2002 | CN1369557A Process for extracting peroxidase from tender leaves of sugar cane |
09/18/2002 | CN1090970C Process for preparing uropoly acid-peptide compsn. |
09/17/2002 | US6451987 Ion exchange chromatography of proteins and peptides |
09/17/2002 | US6451986 Conjugating a protein with polyethylene glycol (peg), by deleting amino residue(s); for example, replacing protein arginine residues with lysine residues that provide a peg attachment site; bioactivity |
09/17/2002 | US6451975 Mixing with acid to solubilize; precipitation; free of myofibrils and sarcomeres |
09/17/2002 | US6451974 Method of acylating peptides and novel acylating agents |
09/17/2002 | US6451968 Hoogsteen type base pairing in triplex motif; diagnosis; heat resistance; detection of point mutations, restriction enzyme sites, and transcription inhibition |
09/17/2002 | US6451591 Device and method for the determination of protein domain boundaries |
09/17/2002 | US6451562 Polypeptides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) polynucleotides |
09/17/2002 | US6451561 Growth hormone variants |
09/17/2002 | US6451543 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
09/17/2002 | US6451541 Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPsc |
09/17/2002 | US6451536 Products for detecting nucleic acids |
09/17/2002 | US6451347 Complexing oxidized or deamidated human growth hormone with metal; precipitation, isolation |
09/17/2002 | US6451307 3′-exonuclease, production and use thereof |
09/17/2002 | US6450681 Dissolving in liquid; agitation |
09/17/2002 | CA2278878C Very large scale immobilized peptide synthesis |
09/17/2002 | CA2111853C Substantially pure receptor like tgf-.beta.1 binding molecules and uses thereof |
09/17/2002 | CA2072420C Storage of materials |
09/12/2002 | WO2002071072A2 Method and device for processing proteins in gels |
09/12/2002 | WO2002071048A1 A process for the separation of biocomponents on a substrate surface |
09/12/2002 | WO2002070565A2 High-affinity antagonists of elr-cxc chemokines |
09/12/2002 | WO2002070547A1 Template-fixed peptidomimetics with antimicrobial activity |
09/12/2002 | WO2002070111A2 Method for the manufacture of gradient gels and method for analysing biomolecules on ultra-long ipg gels |
09/12/2002 | WO2001077335A3 Listeria monocytogenes genome, polypeptides and uses |
09/12/2002 | WO2001071346A3 Binding compounds for cc chemokine receptor 5 and methods for identifying them |
09/12/2002 | WO2001040232A9 Chlorophyll and bacteriochlorophyll esters, and their preparation |
09/12/2002 | WO2001019852A3 Methods of peptide preparation |
09/12/2002 | US20020128453 Generating immunoglobulin; obtain blood sample, incubate with pepsin, remove decomposed products, recover immunoglobulins |
09/12/2002 | US20020128180 Purification method |
09/12/2002 | US20020127603 Methods for synthesizing reporter labeled beads |
09/12/2002 | US20020127587 Isolation of preferential macromolecules; obtain sample, expose to filter with increasing pore size, recover macromolecules |
09/12/2002 | US20020127564 Monitoring modulators of phenotypic expression in mammalian cells; obtain cell, transform, screen transformed cells for preferential phenotype |
09/12/2002 | US20020127244 Fractionating a mixture of polyethylene glycol(PEG)-protein adducts comprising partitioning the PEG/protein adducts in a PEG-containing aqueous biphasic system |
09/12/2002 | CA2439178A1 Template-fixed peptidomimetics with antimicrobial activity |
09/11/2002 | EP1239288A1 Identification of nucleotides, amino acids, or carbohydrates by mass spectrometry |
09/11/2002 | EP1237936A1 Molecularly inprinted polymers produced by template polymerisation |
09/11/2002 | EP0832098B1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
09/11/2002 | CN1368505A Material and process for extracting and purifying DNA, RNA and protein |
09/10/2002 | US6448382 Loading a mixture of isoforms onto a tsk sulfopropyl cation exchange chromatography column, washing with linear gradient buffer, discarding fraction comprising double clipped isoform and collecting intact and single-clipped isoforms |
09/10/2002 | US6448374 Production of phosphopeptides from casein |
09/10/2002 | US6448263 Synthesis routes for such as 2-amino-n-(2-(3a-(r)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo -(4,3-c) pyridin-5-yl)-1-(r)-benzyloxymethyl-2-oxo-ethyl)-isobutyramide l-tartaric acid salt |
09/10/2002 | US6448041 Colon cancer marker |
09/10/2002 | US6448033 Incubating a sample of ribosomes obtained from a cell-free extract with plasmid dna containing a coding sequence for a protein of interest with an aminoacyl trna having fluorescent label |
09/10/2002 | CA2108678C Production of phosphopeptides from casein |
09/08/2002 | CA2363461A1 Methods for producing proteins by using cell-free protein synthesis systems |
09/06/2002 | WO2002068933A2 Small molecule design against drug resistant mutants using directed evolution |
09/06/2002 | WO2002068927A2 Using viruses to detect or purify proteins |
09/06/2002 | WO2002068671A1 Method of deamidation of milk protein and method of denaturation of milk protein |
09/06/2002 | WO2002068456A1 Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs |
09/06/2002 | WO2002068455A2 Efficient recovery of correctly refolded proteins |
09/06/2002 | WO2002068452A2 Method of isolating charged compounds, especially peptides and proteins |
09/06/2002 | WO2002067859A2 Ascorbic acid analogs for metalloradiopharmaceuticals |
09/06/2002 | WO2002002150A3 Stable radioiodine conjugates and methods for their synthesis |
09/06/2002 | WO2001048485A9 Selecting library members capable of binding to epitopes |
09/06/2002 | CA2756609A1 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
09/06/2002 | CA2438204A1 Ascorbic acid analogs for metalloradiopharmaceuticals |
09/05/2002 | US20020123101 Process for producing peptides by using in vitro transcription/translation system |
09/05/2002 | US20020123032 Detection of disease related genes |
09/05/2002 | US20020122769 Buffering reagents, chelating agents and stabilizers |
09/04/2002 | EP1235854A1 Method of separating prions from biological materials |